Skip to main content

CAR-T: A patient’s cell therapy success story

Clinical trials of (CAR) T-cell therapies can present unprecedented enrolment challenges. How can we encourage participation in these trials? Doug Olson, one of the first CAR-T patients treated on a clinical trial, shares his experiences with Alberto Grignolo, Parexel's Corporate Vice President, Regulatory Consulting Services.

Visit www.parexel.com/neverstop to learn how our Regulatory & Access experts can help apply patient insights to your strategy.